Joseph Kleine, CEO of Doximity, has been a key figure in the company’s journey to revolutionize healthcare connectivity. With a career that began in business administration, his focus has been on building tools for healthcare providers that make their work...

Joseph Kleine, CEO of Doximity, has been a key figure in the company’s journey to revolutionize healthcare connectivity. With a career that began in business administration, his focus has been on building tools for healthcare providers that make their work easier. In early 2022, he transitioned from Chief Commercial Officer to an advisory role, reflecting a strategic shift in his career. He was instrumental in the company's growth, leading innovative initiatives that enhanced the support for clinicians and improved patient care access. In 2021, his compensation highlighted a significant sum of around $1.04 million, showing his value to the company, even though in 2022 he opted for a more modest package of $243,726 as he focused on aligning his interests with those of shareholders. As a testament to his investment in Doximity’s success, he holds substantial shares, which emphasize his commitment. Joseph's trajectory illustrates a blend of business acumen and dedication to impactful work in health technology, making him a noteworthy leader in this fast-evolving field.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Doximity CEOs

D

Joseph Kleine

Ex-CEO of Doximity

Education

Bachelor's degree in Business Administration

Field of Expertise

Business & Management

Sector of Economy

Healthcare

Born

February 1, 1972 - 53 years ago

CEO of Doximity for

0 years 6 months (Aug 2021 - Feb 2022)

Previous Experience

Chief Commercial Officer at Doximity, Inc.

Rivals

Competitors/colleagues of Joseph Kleine

Holdings

See how much did Joseph Kleine make over time.

Joseph Kleine's stock holdings paint an interesting picture of his investment in Doximity. His wealth has seen fluctuations, peaking when he served as Chief Commercial Officer but adjusting as he transitioned roles in 2022. His holdings consist mainly of Class...

Joseph Kleine's stock holdings paint an interesting picture of his investment in Doximity. His wealth has seen fluctuations, peaking when he served as Chief Commercial Officer but adjusting as he transitioned roles in 2022. His holdings consist mainly of Class B shares, which grant him substantial voting power within the company. At one point, his grants amounted to over $735,938 in value based on performance metrics. However, he reduced his direct share package upon becoming an advisor. This strategic move reflects a shift in his approach — from a hands-on executive to more of a guiding influencer, while actively participating in the company's vision through retained stock. These varied stakes indicate not just a personal interest but an intense dedication to Doximity's future.

Total Stock Sold

$15.20M

DOCS

$15.20M

200,000 DOCS shares

What if they kept their stock?

If Joseph Kleine didn't sell their stock, today they would have:
Extra DOCS200,000 shares worth $10.60M.
This is -30.27% and $4.60M less than what they got when they sold the stock.

Insider Trading

See recent insider trades of Joseph Kleine.

DOCS

$15.57M

DOCS at $77.84/share

Aug 13, 2021

Sale

Compensation History

See how much did Joseph Kleine make over time.

In the financial year 2022, Joseph Kleine's total compensation with Doximity was reported at $243,726. Notably, his $240,000 base salary was balanced by a smaller amount in other benefits, focusing on long-term stockholder alignment rather than immediate performance bonuses. This is a shift from his earlier role in 2021, where his earnings were as high as $1.04 million due to performance bonuses and vested stock awards amounting to significant increases in wealth. While he initially thrived on performance-based compensation, his recent strategy appears to be more about maintaining substantial equity stakes in Doximity rather than maximizing immediate cash benefits. This change underscores a trust in the company's potential growth, showing a thoughtful approach towards his remuneration as he transitions into a different leadership capacity.

Year

2022

Total Compensation

$243.73K

Salary

$240.00K

Board Justification

The compensation program aims to attract, retain, and reward top management while aligning their interests with stockholders through performance-based incentives.

Bonus

$0.00

Board Justification

No performance-based cash incentive was provided for fiscal year 2023 due to sufficient existing equity holdings.

Other

$3.73K

Board Justification

Includes 401(k) matching contributions and company-paid group life insurance premiums.

Restricted Stock

$0.00(0 RSU)

Board Justification

No stock awards vested in 2022 as no new grants were made for fiscal year 2023.

Performance Metrics

No performance metrics were established for fiscal year 2023.

Other Doximity CEOs

Here are other CEOs of Doximity

Craig Overpeck

Founder and CEO of Doximity

May 2023 - Present